News

Leading the way in targeted cancer treatment

Tumour-on-a-chip offers insight into cancer-fighting cells in immunotherapy

Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma

Scientists uncover new driver of ovarian cancer spread

Outdoor air pollution linked to higher incidence of breast cancer

New study may transform diagnosis of Britain’s number one cancer

Making cancer vaccines more personal

The role of WNT signaling in cancer: from mechanisms to therapeutics

Vitamin-engineered nanoplatforms: Revolutionising precision oncology through immunotherapy, drug delivery, and theranostics

FDA approves revumenib for relapsed or refractory acute myeloid leukaemia with a susceptible NPM1 mutation

FDA approves belantamab mafodotin-blmf for relapsed or refractory multiple myeloma

Common jobs held by immigrant women may put them at increased risk of breast cancer